Effect Of Sleep Apnea Treatment On Temporo-Mandibular Disorders

Anna Alessandri Bonetti

Status: Completed

Conditions: Pain, Face; Sleep Apnea Syndromes; Sleep Apnea, Obstructive; Temporomandibular Disorder; Sleep Apnea; Pain

Treatments: Other: no treatment; Combination Product: osa treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT04948541

3928

Details and patient eligibility

About

Aims of this research are to detect if an improvement in sleep pattern in patients suffering from obstructive sleep apnea (OSA), produces a reduction in pain and dysfunction in the orofacial area by examining variation in temporo-mandibular disorder (TMD) signs and symptoms and if the prevalence of TMDs in OSA patients controlling this disease decreases to levels comparable to healthy subjects.

41 OSA patients will undergo a complete TMD examination prior to start any OSA treatment and after at least 18 months of therapy. Variations in TMD signs and symptoms will be recorded.

Full description

Since a bidirectional relationship has been suggested for poor sleep and pain and considering that patients suffering from obstructive sleep apnea (OSA) have been reported to present a higher prevalence of temporo-mandibular disorder (TMD) signs and symptoms compared to healthy controls; aims of this research are to detect if an improvement in sleep pattern in patients suffering from OSA, produces a reduction in pain and dysfunction in the orofacial area by examining variation in TMD signs and symptoms and if the prevalence of TMDs in OSA patients controlling this disease decreases to levels comparable to healthy subjects.

41 OSA patients will undergo a complete TMD examination prior to start any OSA treatment and after at least 18 months of therapy. Variations in TMD signs and symptoms will be recorded.

Enrollment: 40 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients suffering from OSA diagnosed by polysomnography not yet undergoing treatment

Exclusion criteria

• patients presenting some kind of cognitive impairment, due to difficulties in undergoing TMD examination
• patients presenting dental problems
• patients assuming medications that would alter pain perception
• patients not signing the informed consent

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

treatment

Experimental group

Treatment:

Combination Product: osa treatment

no treatment

Experimental group

Treatment:

Other: no treatment